Neurofibromatosis Type 2 (NF2) Gene Mutation Analysis
Neurofibromatosis type 2 (NF2) is an autosomal dominant disorder that predisposes individuals to develop multiple benign tumors of the nervous system. Clinically, NF2 is characterized by bilateral vestibular schwannomas with associated symptoms of tinnitus, hearing loss, and balance disturbances. Such vestibular schwannomas typically appear between ages of 18-24 and almost all patients develop them by age 30. Affected individuals may develop schwannomas at other locations in addition to meningiomas, gliomas, neurofibromas, ependymomas and rarely astrocytomas. The earliest manifestation of NF2 may be seen in children who develop posterior subcapsular cataracts in one or both eyes. The incidence of NF2 is estimated to be 1 in 33,000 people worldwide.
NF2 is caused by mutations of the NF2 gene on chromosome 22 that encodes for the merlin protein (also known as schwannomin). Merlin is a cell membrane associated protein that acts as a tumor suppressor. Inherited or de novo mutations after ferilization in one NF2 gene combined with a somatic mutation or loss of the second NF2 allele leads to unregulated growth and division of Schwann cells and the development of schwannomas. Identification of heterozygous pathogenic variants in NF2 by molecular genetic testing is useful for the confirmation of NF2 and to provide prognostic information for patient treatment.
- Diagnostic confirmation of Neurofibromatosis Type 2
- Prenatal diagnosis for known familial mutation(s) in at-risk pregnancies
- Early diagnosis and management of disease.
Negative for mutation or pathogenic variant in NF2 gene
Whole blood, buccal swab.
Stability
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: Unacceptable
- Orphanet J Rare Dis. 2009. [PMID: 19545378]
- Hum Mol Genet. 1998. [PMID: 9817927]
- Lancet. 2009;373: 1974-86. [PMID: 19476995]
- J Med Genet. 1995;32: 470-4. [PMID: 7666400]
- J Laryngol Otol. 1995;109: 830-5. [PMID: 7494114]
- Am J Hum Genet. 1994;55: 69-73. [PMID: 8023853]
- Genetics Home Reference. available at: https://ghr.nlm.nih.gov/condition/neurofibromatosis-type-2#
- Genetics Home Reference. available at: https://ghr.nlm.nih.gov/gene/NF2#
- GeneReviews® [Internet].Available at: https://www.ncbi.nlm.nih.gov/books/NBK1201/